Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21095264rdf:typepubmed:Citationlld:pubmed
pubmed-article:21095264lifeskim:mentionsumls-concept:C0008976lld:lifeskim
pubmed-article:21095264lifeskim:mentionsumls-concept:C0027051lld:lifeskim
pubmed-article:21095264lifeskim:mentionsumls-concept:C0014822lld:lifeskim
pubmed-article:21095264lifeskim:mentionsumls-concept:C0021308lld:lifeskim
pubmed-article:21095264lifeskim:mentionsumls-concept:C0600519lld:lifeskim
pubmed-article:21095264lifeskim:mentionsumls-concept:C0301630lld:lifeskim
pubmed-article:21095264lifeskim:mentionsumls-concept:C1707689lld:lifeskim
pubmed-article:21095264lifeskim:mentionsumls-concept:C2699007lld:lifeskim
pubmed-article:21095264pubmed:issue5lld:pubmed
pubmed-article:21095264pubmed:dateCreated2010-11-24lld:pubmed
pubmed-article:21095264pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21095264pubmed:abstractTextAcute myocardial infarction (MI) remains a leading cause of death despite advances in pharmacologic and percutaneous therapies. Animal models of ischemia/reperfusion have demonstrated that single-dose erythropoietin may reduce infarct size, decrease apoptosis, and increase neovascularization, possibly through mobilization of endothelial progenitor cells.lld:pubmed
pubmed-article:21095264pubmed:languageenglld:pubmed
pubmed-article:21095264pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21095264pubmed:citationSubsetAIMlld:pubmed
pubmed-article:21095264pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21095264pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21095264pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21095264pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21095264pubmed:statusMEDLINElld:pubmed
pubmed-article:21095264pubmed:monthNovlld:pubmed
pubmed-article:21095264pubmed:issn1097-6744lld:pubmed
pubmed-article:21095264pubmed:authorpubmed-author:LongoDan LDLlld:pubmed
pubmed-article:21095264pubmed:authorpubmed-author:HarringtonRob...lld:pubmed
pubmed-article:21095264pubmed:authorpubmed-author:LakattaEdward...lld:pubmed
pubmed-article:21095264pubmed:authorpubmed-author:KimRaymond...lld:pubmed
pubmed-article:21095264pubmed:authorpubmed-author:KilaruRakhiRlld:pubmed
pubmed-article:21095264pubmed:authorpubmed-author:RaoSunil VSVlld:pubmed
pubmed-article:21095264pubmed:authorpubmed-author:FerrucciLuigi...lld:pubmed
pubmed-article:21095264pubmed:authorpubmed-author:PatelManesh...lld:pubmed
pubmed-article:21095264pubmed:authorpubmed-author:MelloniChiara...lld:pubmed
pubmed-article:21095264pubmed:authorpubmed-author:PovsicThomas...lld:pubmed
pubmed-article:21095264pubmed:authorpubmed-author:NajjarSamer...lld:pubmed
pubmed-article:21095264pubmed:authorpubmed-author:TalanMarkMlld:pubmed
pubmed-article:21095264pubmed:authorpubmed-author:MeltonLauraLlld:pubmed
pubmed-article:21095264pubmed:copyrightInfoCopyright © 2010 Mosby, Inc. All rights reserved.lld:pubmed
pubmed-article:21095264pubmed:issnTypeElectroniclld:pubmed
pubmed-article:21095264pubmed:volume160lld:pubmed
pubmed-article:21095264pubmed:ownerNLMlld:pubmed
pubmed-article:21095264pubmed:authorsCompleteYlld:pubmed
pubmed-article:21095264pubmed:pagination795-803.e2lld:pubmed
pubmed-article:21095264pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:21095264pubmed:meshHeadingpubmed-meshheading:21095264...lld:pubmed
pubmed-article:21095264pubmed:meshHeadingpubmed-meshheading:21095264...lld:pubmed
pubmed-article:21095264pubmed:meshHeadingpubmed-meshheading:21095264...lld:pubmed
pubmed-article:21095264pubmed:meshHeadingpubmed-meshheading:21095264...lld:pubmed
pubmed-article:21095264pubmed:meshHeadingpubmed-meshheading:21095264...lld:pubmed
pubmed-article:21095264pubmed:meshHeadingpubmed-meshheading:21095264...lld:pubmed
pubmed-article:21095264pubmed:meshHeadingpubmed-meshheading:21095264...lld:pubmed
pubmed-article:21095264pubmed:meshHeadingpubmed-meshheading:21095264...lld:pubmed
pubmed-article:21095264pubmed:meshHeadingpubmed-meshheading:21095264...lld:pubmed
pubmed-article:21095264pubmed:meshHeadingpubmed-meshheading:21095264...lld:pubmed
pubmed-article:21095264pubmed:meshHeadingpubmed-meshheading:21095264...lld:pubmed
pubmed-article:21095264pubmed:meshHeadingpubmed-meshheading:21095264...lld:pubmed
pubmed-article:21095264pubmed:meshHeadingpubmed-meshheading:21095264...lld:pubmed
pubmed-article:21095264pubmed:meshHeadingpubmed-meshheading:21095264...lld:pubmed
pubmed-article:21095264pubmed:meshHeadingpubmed-meshheading:21095264...lld:pubmed
pubmed-article:21095264pubmed:meshHeadingpubmed-meshheading:21095264...lld:pubmed
pubmed-article:21095264pubmed:meshHeadingpubmed-meshheading:21095264...lld:pubmed
pubmed-article:21095264pubmed:meshHeadingpubmed-meshheading:21095264...lld:pubmed
pubmed-article:21095264pubmed:year2010lld:pubmed
pubmed-article:21095264pubmed:articleTitleDesign and rationale of the Reduction of Infarct Expansion and Ventricular Remodeling with Erythropoietin after Large Myocardial Infarction (REVEAL) trial.lld:pubmed
pubmed-article:21095264pubmed:affiliationDivision of Cardiology, Department of Medicine, Duke University School of Medicine, Durham, NC, USA. chiara.melloni@duke.edulld:pubmed
pubmed-article:21095264pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:21095264pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:21095264pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:21095264pubmed:publicationTypeMulticenter Studylld:pubmed
pubmed-article:21095264pubmed:publicationTypeClinical Trial, Phase IIlld:pubmed
pubmed-article:21095264pubmed:publicationTypeResearch Support, N.I.H., Intramurallld:pubmed